Real-World Evidence Shows Cost Effectiveness of Offering NIPT to All Pregnant Women
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
This proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.
The preeclampsia detection kit is a highly accurate, urine-based, noninvasive point-of-care test, meaning no specialized instrumentation or equipment is needed.
Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.
Read MoreApril 2019’s product spotlight includes immunoassay kits and analyzers from companies such as Fujirebio, Ansh Labs, Tosoh Bioscience, and more.
Read MoreApril 2019’s product spotlight includes immunoassay kits and analyzers from companies such as Fujirebio, Ansh Labs, Tosoh Bioscience, and more.
Read MoreThe test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.
Read MoreThe Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.
Read MoreA novel multiplexing platform called ‘high definition polymerase chain reaction’ brings together widely used, low-cost chemistries and qPCR instrumentation with proprietary data science algorithms to enable streamlined multiplex test development and very affordable test deliverables.
Read MoreThe nationwide study showed worrisome beliefs surrounding cardiac health and disease prevention.
Read MoreEnhanced test improves detection of chromosomal abnormalities by 30%.
Read MoreThe addition allows for easier validation of laboratory-developed tests, documentation of linearity and calibration verification, and verification of reportable range.
Read MoreThe current generation of instruments for in vitro diagnostics is helping to support clinical labs through a strong emphasis on automation.
Read MoreThe ResistancePlus GC molecular diagnostic simultaneously diagnoses N. gonorrhoeae and provides antimicrobial susceptibility information, overcoming many of the issues associated with culture-based methods.
Read MoreHologic’s first-in-category assay, cleared through FDA’s De Novo review process, provides laboratories with a highly sensitive and specific molecular diagnostic method to identify M. genitalium infections and enable effective treatment.
Read MoreThe kit assists laboratories in documenting their linearity and calibration verification for hs-CRP, NT-proBNP, and TnI assays.
Read MoreThe Parsortix system offers the potential to extend NIPT to a wide range of conditions not feasible with existing techniques.
Read MoreThe MenoCheck assay was developed to aid physicians in determining the status of women during menopausal transition.
Read More